Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


ENANTA PHARMA   FYE=9 (September)

Annual - Income Statement - Company Specific

Fiscal period2022202120202019201820172016201520142013
Period End Date9/30/20229/30/20219/30/20209/30/20199/30/20189/30/20179/30/20169/30/20159/30/20149/30/2013
Revenue--------------------
Royalties86.1697.07122.47205.20191.6337.8157.6934.080.00--
Milestone payments--------15.0065.0030.00125.0040.0026.00
Revenue-Other------------0.581.807.746.05
Total Revenues86.1697.07122.47205.20206.63102.8188.27160.8847.7432.05
Research and development164.52174.11136.76142.2194.8657.4540.4623.1918.7416.84
General and Administrative45.4832.5427.3626.2523.4420.7516.9713.5410.026.18
Total Operating Expenses210.00206.65164.11168.46118.3078.2057.4336.7328.7623.02
Income (Loss) from operations(123.84)(109.57)(41.64)36.7488.3324.6130.84124.1518.999.03
Interest expense--------------0.010.020.03
Interest income1.572.026.478.824.852.491.690.970.470.25
Other income (expense), net--------------------
Change in fair value of warrant liability0.08(0.03)0.15--(0.06)(0.16)0.030.35(0.17)0.38
Therapeutic tax credit--------------------
Gain on embedded derivative--------------------
Total other income (expense), net1.661.996.628.824.79--1.721.310.280.60
Income (loss) before income tax(122.19)(107.58)(35.02)45.5693.1226.9532.56125.4619.279.63
Income tax benefit(0.43)(28.58)1.15(0.83)21.179.2410.8946.46(15.17)--
Net Income (loss)(121.76)(79.00)(36.17)46.3871.9617.7121.6778.9934.449.63
Accretion of redeemable convertible preferred stock to redemption value------------------2.53
Net income attributable to participating securities------------------13.67
Net Income (loss) attributable to common stockholders(121.76)(79.00)(36.17)46.3871.9617.7121.6778.9934.44(6.57)
Net income (loss) per share attributable to common stockholders :Basic(5.91)(3.92)(1.81)2.373.740.931.144.231.88(0.67)
Net income (loss) per share attributable to common stockholders :Diluted(5.91)(3.92)(1.81)2.213.480.911.134.091.80(0.67)
Weighted average common shares outstanding:Basic20.6020.1719.9419.5819.2619.0718.9318.6718.369.79
Weighted average common shares outstanding:Diluted20.6020.1719.9420.9720.6519.4119.2219.3019.199.79